The silver lining is the consortium allegedly has expertise in helping healthcare companies transition from R&D to drug commercialisation. How much they will move the needle here, who knows. But it’s good to see that they approached IHL first, must mean they expect good things in future. I think patience will certainly pay here but people are being far too optimistic about the shorter term imo. Let’s hope we have created a lot of value before the next cap raise in 2025 (unless they do another dilutive raise as a discount to the market after emphasising how well funded they are).
- Forums
- ASX - By Stock
- IHL
- Ann: Incannex Undertakes A$13 Million Institutional Placement
Ann: Incannex Undertakes A$13 Million Institutional Placement, page-26
-
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online